从未沮丧 发表于 2025-3-21 17:38:17
书目名称Chemokines影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0224912<br><br> <br><br>书目名称Chemokines读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0224912<br><br> <br><br>去才蔑视 发表于 2025-3-21 23:25:35
Nuska TschammerOverview chapters introduce the newcomer to the topic covered.Series covers hot topics of frontier research summarized by reputed scientists in the field.Volumes are useful and of relevance for a longOversee 发表于 2025-3-22 02:57:09
Topics in Medicinal Chemistryhttp://image.papertrans.cn/c/image/224912.jpgBILE 发表于 2025-3-22 05:42:03
http://reply.papertrans.cn/23/2250/224912/224912_4.png繁忙 发表于 2025-3-22 09:24:45
http://reply.papertrans.cn/23/2250/224912/224912_5.png艺术 发表于 2025-3-22 16:37:41
,Einfluß des Stichprobenumfangs n,coupled receptors, which represent one of the most druggable classes of proteins. In this review we will examine the role of chemokines in autoimmunity and inflammation by concentrating on the part they play in the pathophysiology of several diseases including asthma, multiple sclerosis, and rheumat艺术 发表于 2025-3-22 20:18:44
http://reply.papertrans.cn/23/2250/224912/224912_7.png戏法 发表于 2025-3-22 23:55:07
http://reply.papertrans.cn/23/2250/224912/224912_8.png曲解 发表于 2025-3-23 05:24:10
https://doi.org/10.1007/978-3-322-87917-2ng evidence for a role of CCR2 and CCR5 receptors in human inflammatory diseases led to a growing interest in CCR2- and CCR5-selective antagonists. In this review, we focus on the recent development of selective CCR2/CCR5 receptor ligands and dual antagonists. Several compounds targeting CCR2, e.g.,开花期女 发表于 2025-3-23 06:59:47
http://reply.papertrans.cn/23/2250/224912/224912_10.png